Hôpital Necker Immunologie Clinique Unité de Recherche de l'INSERM U25 (External organisation)

Activity: Membership › Membership of external research organisation

Description

Phase II therapeutic trial with a humanized non-mitogenic CD3 (ChAgly) monoclonal antibody in recently diagnosed type 1 diabetic patients

Period	1 Dec 1997
Held at	Hôpital Necker Immunologie Clinique Unité de Recherche de l'INSERM U25, France